Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Emergency Use Authorization for Gene-RADAR® Zika Virus Test: FDA Authorization for the Gene-RADAR® Zika Virus Test on the XPRIZE-Winning Gene-RADAR® Platform

Abstract:
Nanobiosym Diagnostics Inc. (Nanobiosym) today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Gene-RADAR® Zika Virus Test.

Emergency Use Authorization for Gene-RADAR® Zika Virus Test: FDA Authorization for the Gene-RADAR® Zika Virus Test on the XPRIZE-Winning Gene-RADAR® Platform

Cambridge, MA | Posted on April 14th, 2017

Nanobiosym Diagnostics Inc. (Nanobiosym) today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Gene-RADAR® Zika Virus Test.

Dr. Anita Goel, M.D., Ph.D., demonstrates the highly portable Gene-RADAR device to NASA scientists.

"This FDA EUA represents a major milestone towards realizing our deeper vision: to decentralize, personalize, and mobilize the next generation of healthcare, much like cell phones transformed the telecommunications industry," said Dr. Anita Goel, M.D., Ph.D., Chairman and CEO of Nanobiosym and a Harvard-MIT trained physicist and physician. "The FDA's prompt feedback has accelerated our journey from winning the first XPRIZE for healthcare to bringing this new technology to patients and providers battling Zika on the front lines."

According to the Centers for Disease Control (CDC), more than 43,000 people in the U.S. and its territories have already been infected by the Zika virus, including at least 4,750 pregnant women. One of the greatest threats of Zika infection occurs during pregnancy, potentially resulting in significant neurological problems in the developing baby, such as severe microcephaly, decreased brain tissue and brain damage.

Currently, Zika virus RNA has been detected in serum up to 13 days post-symptom onset in non-pregnant patients, up to 62 days post-symptom onset in pregnant patients and up to 53 days after the last known possible exposure in an asymptomatic pregnant woman. In addition, recent studies have demonstrated Zika virus RNA detection in semen and whole blood 34 days1 and two months2 post-infection, respectively. The Gene-RADAR® Zika Virus Test should be performed according to CDC's algorithm for Zika testing (see http://www.cdc.gov/zika/laboratories/lab-guidance.html).

"Access to this important new testing technology represents an important breakthrough in 'real-time' Zika testing, and partnering with Nanobiosym allows us to bring cutting-edge Gene-RADAR® testing to our patients here in Florida," said Dr. D.T. Jayaweera, M.D., Executive Dean for Infectious Disease Research at the Miller School of Medicine at the University of Miami, which has signed a Memorandum of Understanding with Nanobiosym to evaluate the real-world clinical and operational utility of the Gene-RADAR® platform. "Mitigating the further spread of Zika virus infection in Florida and effectively managing the spectrum of neurological problems in newborn babies and adults is a top priority for us."


1 Driggers, R.W., et al. Zika virus infection with Prolonged Maternal Viremia and Fetal
Brain Abnormalities. New England Journal of Medicine, June 2, 2016; 374:2142-2151.
DOI: 10.1056/NEJMoa1601824

2 Meaney-Delman et al. Prolonged Detection of Zika Virus RNA in Pregnant Women.
Obstetrics and Gynecology, 128:724-730. DOI: 10.1097/AOG.0000000000001625

####

About Nanobiosym Diagnostics Inc.
Nanobiosym Diagnostics aims to bring the XPRIZE-winning Gene-RADAR® platform technology to over four billion people on the planet that currently lack access to basic healthcare. In addition to the Gene-RADAR® Zika Virus Test that has been granted an Emergency Use Authorization by the FDA, the Company is developing expanded clinical sample input options to include other body fluids such as whole blood and urine. Currently, the Gene-RADAR® Zika Virus Test has only been authorized for the detection of RNA from Zika virus in human serum, not for any other body fluids or any other viruses or pathogens.

The Nanobiosym Research Institute focuses on creating breakthrough scientific insights and developing transformational technologies that emerge from the convergence of physics, nanotechnology, and biomedicine. Nanobiosym has been awarded several prestigious peer-reviewed awards and grants from U.S. federal agencies, including DARPA, NSF, DOD, DOE, CASIS (in affiliation with NASA), and USAID. Nanobiosym, under Dr. Goel's leadership, is harnessing the science of nanobiophysics to develop and clinically validate a pipeline of novel "apps" for the Gene-RADAR® Platform as well as enhance the mobility and other performance metrics of the underlying platform.

For more information, visit www.nanobiosym.com or follow @Nanobiosym on Twitter.

For more information, please click here

Copyright © Nanobiosym Diagnostics Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Full Nanobiosym Gene-RADAR® Zika Virus Test EUA at:

Further details about the Zika Virus in the U.S. and worldwide at:

Related News Press

News and information

Supersonic waves may help electronics beat the heat May 18th, 2018

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Disability Can Be a Superpower in Space Disabled astronauts offer unique solutions to emergencies in space May 17th, 2018

Deeper understanding of quantum chaos may be the key to quantum computers May 16th, 2018

Govt.-Legislation/Regulation/Funding/Policy

Supersonic waves may help electronics beat the heat May 18th, 2018

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Deeper understanding of quantum chaos may be the key to quantum computers May 16th, 2018

Team achieves two-electron chemical reactions using light energy, gold May 15th, 2018

Possible Futures

Supersonic waves may help electronics beat the heat May 18th, 2018

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Disability Can Be a Superpower in Space Disabled astronauts offer unique solutions to emergencies in space May 17th, 2018

Deeper understanding of quantum chaos may be the key to quantum computers May 16th, 2018

Nanomedicine

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Elastic microspheres expand understanding of embryonic development and cancer cells May 15th, 2018

Nanomedicine -- Targeting cancer cells with sugars May 14th, 2018

NanoBio Announces Corporate Name Change to BlueWillow Biologics and Closes $10M Series A Financing: Move Reflects Focus on Advancing Several Intranasal Vaccines to Human Studies May 9th, 2018

Announcements

Supersonic waves may help electronics beat the heat May 18th, 2018

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Disability Can Be a Superpower in Space Disabled astronauts offer unique solutions to emergencies in space May 17th, 2018

Deeper understanding of quantum chaos may be the key to quantum computers May 16th, 2018

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

Supersonic waves may help electronics beat the heat May 18th, 2018

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Deeper understanding of quantum chaos may be the key to quantum computers May 16th, 2018

Making carbon nanotubes as usable as common plastics: Researchers discover that cresols disperse carbon nanotubes at unprecedentedly high concentrations May 15th, 2018

Nanobiotechnology

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Nanomedicine -- Targeting cancer cells with sugars May 14th, 2018

NanoBio Announces Corporate Name Change to BlueWillow Biologics and Closes $10M Series A Financing: Move Reflects Focus on Advancing Several Intranasal Vaccines to Human Studies May 9th, 2018

Nanoscale measurements 100x more precise, thanks to improved two-photon technique May 8th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project